• Australian Clinical Labs Limited


  • Healius Limited

Australian Clinical Labs Limited (ACL) is seeking to acquire Healius Limited (Healius) by way of an off-market takeover offer to acquire all the fully paid ordinary shares in Healius.

ACL and Healius provide human pathology services to out-patients, in-patients (at public and private hospitals), and commercial and government customers, as well as veterinary pathology services. Healius also provides diagnostic imaging services.

Market inquiries

Document title Date
ACL Healius - market inquiries letter


Date Event

ACCC commenced review under the Merger Process Guidelines.

Closing date for submissions.

Former provisional date for announcement of ACCC’s findings (22 June) delayed at ACL’s request. ACCC will announce a revised provisional decision date in due course. 

Project staff

  • Claudia Gulbransen-Diaz
  • Lucia Moschis

Contact email